Serum Procalcitonin as a Biomarker to Determine the Duration of Antibiotic Therapy in Adult Patients with Sepsis and Septic Shock in Intensive Care Units: A Prospective Study

BACKGROUND: Procalcitonin, a biomarker to adjudge the duration of antibiotic therapy in patients with sepsis. MATERIALS AND METHODS: A prospective, randomized, controlled, interventional, single-center study was conducted in a mixed adult intensive care unit (ICU). In a nonblinded study, 90 adult pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Vishalashi, SM Gowri, Gupta, Poonam, Verma, Pardeep Kumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Jaypee Brothers Medical Publishers 2021
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196370/
https://www.ncbi.nlm.nih.gov/pubmed/34177168
http://dx.doi.org/10.5005/jp-journals-10071-23802

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8196370/
https://www.ncbi.nlm.nih.gov/pubmed/34177168
http://dx.doi.org/10.5005/jp-journals-10071-23802

Ejemplares similares